Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Pulmonary/Respiratory Diseases | Vaccines | Infections and Infectious Diseases
Influenza Clinical Trials
A listing of Influenza medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Chandler : East Valley Family Physicians, PLC
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
California
Beverly Hills : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Los Angeles : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
North Hollywood : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
San Diego : California Research Foundation
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
San Francisco : Benchmark Research San Francisco
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Colorado
Denver : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Florida
Pinellas Park : Radiant Research - St. Petersburg
Clinical Research for Flu Vaccine
View More »
Coral Gables : Clinical Research of South Florida
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
Coral Gables : Clinical Research of South Florida
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Debary : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Miami : Miami Research Associates
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
Tamarac : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Georgia
Columbus : Southeast Regional Research Group - Columbus
FLU Got You Blue? Ask NOW about a clinical research study that you may qualify for.
Savannah : Southeast Regional Research Group - Savannah
FLU Got You Blue? Ask NOW about a clinical research study that you may qualify for.
View More »
Stockbridge : Clinical Research Atlanta
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Illinois
Chicago : Updated
An Influenza Resistance Information Study (IRIS)
Kansas
Lenexa : Johnson County Clin-Trials
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
Overland Park : Quintiles Early Clinical Development
Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus
Overland Park : Quintiles Early Clinical Development
Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses
Wichita :
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
Wichita : Heartland Research Associates, LLC
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Maryland
Baltimore : SNBL Clinical Pharmacology Center
Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)
Massachusetts
Brockton : Beacon Clinical Research
65+ Flu Vaccine Research Study
View More »
Boston :
A Pharmacokinetic/Pharmacodynamic Study of Tamiflu (Oseltamivir) in Immunocompromised Children With Confirmed Influenza Infection
Springfield : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Michigan
Detroit : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Rochester : Remedica, LLC
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
Missouri
Kansas City : Dybedal Clinical Research Center
Influenza Study
View More »
Kansas City : The Center for Pharmaceutical Research, P.C.
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
St. Louis : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
St. Louis : Sundance Clinical Research, LLC
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Nebraska
Omaha :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Omaha :
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
New York
Rochester : Rochester Clinical Research
Elderly Flu Vaccine
View More »
Brooklyn :
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
New York :
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Rochester : Rochester Clinical Research Inc.
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Syracuse :
A Pharmacokinetic/Pharmacodynamic Study of Tamiflu (Oseltamivir) in Immunocompromised Children With Confirmed Influenza Infection
North Carolina
Cary : PMG Research of Cary, LLC
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Charlotte : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Durham : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
North Dakota
Bismarck : St. Alexius Medical Center
A study of an investigational medication for the treatment of the flu
Ohio
Cleveland : Rapid Medical Research, Inc.
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Toledo : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Oklahoma
Oregon
Pennsylvania
Pittsburgh : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Pittsburgh : University of Pittsburgh, Division of Geriatric Medicine
Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting
South Carolina
Spartanburg : Spartanburg Medical Research
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Texas
Dallas : ACRC TRIALS
Dust Mite Allergy?
Dallas : ACRC TRIALS
Flu got you blue?
San Antonio : Sun Research Institute
Are you suffering from Flu-like symptoms?
San Antonio : Sun Research Institute
FLU got you blue?
View More »
Austin : Benchmark Research Austin
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Fort Worth : Benchmark Research
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Houston : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Utah
Salt Lake City : J. Lewis Research, Inc.
Flu Treatment
View More »
Salt Lake City : Jean Brown Research
Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)
Australia
Brisbane : Capalaba Medical Centre
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B
Brisbane : Taringa 7 Day Medical Practice
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B
Westmead : Updated
An Influenza Resistance Information Study (IRIS)
Belgium
Bruxelles : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Leuven : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Bulgaria
Plovdiv : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Canada
Burlington : Aviva Medical Clinical Trials Group
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Courtice : Co-Medica Research Network
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Halifax : QEII Health Science Centre
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Hamilton : McMaster
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Kitchener : Dr. Sameh Fikry Medicine Professional Corporation
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
View More »
London : Schacter Medicine Professional Corporation
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Mirabel : Omnispec Clinical Research Inc.
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Montreal : MUCH
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Montreal : Metropolitan Clinical Research Centre
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Oshawa : Taunton Health Centre
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Ottawa : Ottawa General
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Pickering : Steeple Hill Medical Centre
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Quebec : CHUl/CHUQ
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Quebec : ALPHA Recherche Clinique
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Saint John : Saint John Regional Hospital
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Sarnia : London Road Diagnostic Clinic and Medical Centre
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Sherbrooke : CHUS
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
St. John's : Paradise Medical Clinic
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Strathroy : DCTM Clinical Trials Group Ltd.
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Surrey : Fraser Health Authority
Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)
Toronto : Mount Sinai Hospital
A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine
Toronto : Mount Sinai
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
Toronto : Dr. Anil Gupta
Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)
Vancouver : Vancouver General
Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults
China
Zhengzhou : Henan Center for Diseases Control and Prevention
The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine
Czech Republic
Parah 5 : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Tabor : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Terezin : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Zlin : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Estonia
Tallinn : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Tartu : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
France
Bron : Updated
An Influenza Resistance Information Study (IRIS)
Lyon : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Tours : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Germany
Berlin : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Berlin : Updated
An Influenza Resistance Information Study (IRIS)
Muenchen : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Hong Kong
Shatin : Updated
An Influenza Resistance Information Study (IRIS)
Hungary
Budapest : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Debrecen : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Gyor : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Gyula : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Pecs : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
View More »
Szekesfehervar : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Szolnok : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Veszprem : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Israel
Jerusalem : Hadassah medical center
A Study to Assess the Safety and Immunogenicity of an IM Influenza Vaccine (Multimeric-001) Followed by Administration of TIV to Elderly Volunteers
Petach Tikva : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Tel Hashomer : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Italy
Brescia : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Monza : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Roma : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Kenya
Kisumu : KEMRI/CDC- IEIP surveillance-Asembo
Seasonal Influenza Vaccine Effectiveness Study in Kenya
Nairobi : KEMRI/CDC IEIP surveillance- Kibera
Seasonal Influenza Vaccine Effectiveness Study in Kenya
Korea, Republic of
Incheon : GSK Investigational Site
Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old
Latvia
Riga : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Lithuania
Kaunas : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Klaipeda : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Siauliai : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Vilnius : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Netherlands
Rotterdam : Updated
An Influenza Resistance Information Study (IRIS)
Poland
Bialystok : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Bydgoszcz : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Krakow : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Krakow : Updated
An Influenza Resistance Information Study (IRIS)
Lodz : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
View More »
Wroclaw : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Russian Federation
Saratov :
A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold
Spain
Madrid :
A Pharmacokinetic/Pharmacodynamic Study of Tamiflu (Oseltamivir) in Immunocompromised Children With Confirmed Influenza Infection
Madrid : Updated
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
Taiwan
Taipei : National Taiwan University Hospital
A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects
Taoyuan County : Chang Gung Memorial Hospital at Linkuo
A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old
United Kingdom
London :
Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza
